Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-20-055957)

Filing Details

Accession Number:: 0001104659-20-055957
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-05-04 09:56:57
Reporting Period:: 2020-04-30

Accepted Time:: 2020-05-04 09:56:57
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1173281	Neubase Therapeutics Inc.	NBSE	Pharmaceutical Preparations (2834)	465622433

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1313876	I Eric Richman	C/O 700 Technology Drive, Third Floor Pittsburgh PA 15219		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-04-30	2,500	$6.00	27,747	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2020-04-30	8,333	$6.00	36,080	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnote
No	4	P	Direct

Footnotes

The power of attorney under which this form was signed is on file with the Commission.
Shares are held in a trust for the benefit of the Reporting Person with the Reporting Person and the Reporting Person's spouse serving as co-trustees.